首页> iScience> High indoleamine 2,3-dioxygenase transcript levels predict better outcome after front-line cancer immunotherapy.

High indoleamine 2,3-dioxygenase transcript levels predict better outcome after front-line cancer immunotherapy.

导出 LinkOut

翻译打印收藏纠错

第一作者： Yu,Fujiwara

第一单位： Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, USA.;Department of Medicine, Icahn School of Medicine at Mount Sinai, Mount Sinai Beth Israel, New York, NY 10003, USA.

作者： Yu,Fujiwara ^[1] ; Shumei,Kato ^[2] ; Daisuke,Nishizaki ^[2] ; Hirotaka,Miyashita ^[3] ; Suzanna,Lee ^[2] ; Mary K,Nesline ^[4] ; Jeffrey M,Conroy ^[4] ; Paul,DePietro ^[4] ; Sarabjot,Pabla ^[4] ; Scott M,Lippman ^[2] ; Razelle,Kurzrock ^[5]

作者单位： Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, USA.;Department of Medicine, Icahn School of Medicine at Mount Sinai, Mount Sinai Beth Israel, New York, NY 10003, USA. ^[1] Center for Personalized Cancer Therapy, University of California, San Diego, Moores Cancer Center, La Jolla, CA 92093, USA. ^[2] Division of Hematology and Oncology, Dartmouth Cancer Center. One Medical Center Drive, Lebanon, NH 03766, USA. ^[3] OmniSeq (Labcorp Oncology), Buffalo, NY 14203, USA. ^[4] MCW Cancer Center and Genomic Sciences and Precision Medicine Center, Medical College of Wisconsin, Milwaukee, WI 53226, USA. ^[5]

关键词 Cancer Immunology Molecular biology

DOI 10.1016/j.isci.2024.109632

PMID 38632994

发布时间 2024-04-26

基金项目

P30 CA023100/CA/NCI NIH HHS/United States U10 CA180888/CA/NCI NIH HHS/United States UG1 CA233198/CA/NCI NIH HHS/United States

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

iScience

2024年27卷4期

109632页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览0

点击下载本期目录封面

iScience

2024年27卷4期

109632页

检索历史清除

High indoleamine 2,3-dioxygenase transcript levels predict better outcome after front-line cancer immunotherapy.

iScience

相似文献

同项目论文

iScience

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

High indoleamine 2,3-dioxygenase transcript levels predict better outcome after front-line cancer immunotherapy.

iScience

相似文献

同项目论文

iScience

相关期刊

检索历史清除